Nozaki H, Fukuuchi Y, Koto A, Tanaka K, Kobari M
Department of Neurology, School of Medicine, Keio University, Tokyo, Japan.
Kekkaku. 1994 Nov;69(11):663-70.
The level of adenosine deaminase (ADA) activity in the cerebrospinal fluid is used as a supportive diagnostic measure for tuberculous meningitis. However the time-course of adenosine deaminase activity of the cerebrospinal fluid in patients with tuberculous meningitis remains unknown. The present study describes 4 patients with tuberculous meningitis in whom ADA activity in the cerebrospinal fluid was serially determined in order to clarify the effects of anti-tuberculous chemotherapy on ADA activity in the cerebrospinal fluid. In two of these patients the ADA did not show a high activity in the early stage of the disease. But in all cases the ADA showed a high activity after all, and gradually declined and reached the normal level at approximately 1 month after the initiation of chemotherapy. It seems that the decrease in the ADA activity was seen when T cells in the cerebrospinal fluid returned to a static state upon removal of mycobacterial antigen by the treatment. The level of ADA in the cerebrospinal fluid is considered to be one of the useful measures for diagnosis and follow-up in patients with tuberculous meningitis.
脑脊液中腺苷脱氨酶(ADA)活性水平被用作结核性脑膜炎的辅助诊断指标。然而,结核性脑膜炎患者脑脊液中腺苷脱氨酶活性的时间进程仍不清楚。本研究描述了4例结核性脑膜炎患者,为阐明抗结核化疗对脑脊液中ADA活性的影响,对其脑脊液中的ADA活性进行了连续测定。其中2例患者在疾病早期ADA活性不高。但最终在所有病例中ADA活性均升高,且逐渐下降,在化疗开始后约l个月降至正常水平。似乎在治疗清除分枝杆菌抗原后,当脑脊液中的T细胞恢复静止状态时,ADA活性会降低。脑脊液中ADA水平被认为是结核性脑膜炎患者诊断和随访的有用指标之一。